Soluble guanylyl cyclase as a therapeutic target in chronic obstructive pulmonary disease (COPD)

被引:0
|
作者
Constantinos Glynos
Dimitris Toumpanakis
Zongmin Zhou
Peter Brouckaert
Theodoros Vassilakopoulos
Andreas Papapetropoulos
机构
[1] University of Athens,George P Livanos and Marianthi Simou Laboratories, Evangelismos Hospital, 1st Department of Pulmonary and Critical Care
[2] University of Patras,Laboratory of Molecular Pharmacology, Department of Pharmacy
[3] Ghent University,Department of Biomedical Molecular Biology
[4] VIB,Department of Molecular Biomedical Research
关键词
Nitric Oxide; Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Airflow Limitation; Smooth Muscle Tone;
D O I
10.1186/2050-6511-14-S1-P25
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] The Role of Soluble Guanylyl Cyclase in Chronic Obstructive Pulmonary Disease
    Glynos, Constantinos
    Dupont, Lisa L.
    Vassilakopoulos, Theodoros
    Papapetropoulos, Andreas
    Brouckaert, Peter
    Giannis, Athanassios
    Joos, Guy F.
    Bracke, Ken R.
    Brusselle, Guy G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (07) : 789 - 799
  • [2] The role of soluble guanylyl cyclase in chronic obstructive pulmonary disease
    Dupont, Lisa
    Glynos, Constantinos
    Vassilakopoulos, Theodoros
    Papapetropoulos, Andreas
    Brouckaert, Peter
    Giannis, Athanassios
    Joos, Guy
    Bracke, Ken
    Brusselle, Guy
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] Therapeutic targets for chronic obstructive pulmonary disease (COPD)
    Sorbera, L. A.
    Bozzo, J.
    Dulsat, C.
    Serradell, N.
    Rosa, E.
    [J]. DRUGS OF THE FUTURE, 2008, 33 (04) : 371 - U4
  • [4] Therapeutic Approaches for Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
    Rosenwasser, Yehudis
    Berger, Irene
    Loewy, Zvi G.
    [J]. PATHOGENS, 2022, 11 (12):
  • [5] Soluble guanylate cyclase as a therapeutic target in pulmonary hypertension
    Eygenov, Olee V.
    [J]. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2010, 22 : S32 - S32
  • [6] PRKCD as a potential therapeutic target for chronic obstructive pulmonary disease
    Li, Siqi
    Huang, Qiong
    Zhou, Dongbo
    He, Baimei
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [7] Therapeutic options in the management of stable chronic obstructive pulmonary disease (COPD)
    Schäfer, H
    Ewig, S
    Gillissen, A
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 125 (08) : 230 - 235
  • [8] Chronic Obstructive Pulmonary Disease (COPD)
    Lareau, Suzanne C.
    Fahy, Bonnie
    Meek, Paula
    Wang, Angela
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (01)
  • [9] Chronic Obstructive Pulmonary Disease (COPD)
    Kostikas, Konstantinos
    Hillas, Georgios
    Michaelides, Stylianos A.
    Kontakiotis, Theodore
    Kosmas, Epameinondas N.
    Tzanakis, Nikolaos
    [J]. PNEUMON, 2012, 25 : 17 - 23
  • [10] Chronic obstructive pulmonary disease (COPD)
    Feetham, Laura
    van Dorn, Aaron
    [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 18 - 19